COPD Disease Presentation
COPD should be suspected in any patient over 40 years old with dyspnea, chronic cough, or sputum production who has significant smoking history (>10 pack-years) or occupational/environmental exposures, and diagnosis must be confirmed with post-bronchodilator spirometry showing FEV1/FVC <0.70. 1
Cardinal Symptoms
Chronic and progressive dyspnea is the most characteristic symptom of COPD and represents the major cause of disability and anxiety in these patients. 1, 2 The breathlessness typically develops gradually over many years and eventually limits daily activities. 2
Chronic cough is often the first symptom and is frequently dismissed by patients as a consequence of smoking or environmental exposures. 1, 2 The cough is typically productive and worse in the morning. 2
Sputum production meeting the classic definition of chronic bronchitis (regular production for 3+ months in 2 consecutive years) is common, though this arbitrary definition doesn't capture the full range of sputum production in COPD. 1 Patients producing large volumes of sputum may have underlying bronchiectasis. 1
Wheezing and chest tightness vary between days and throughout a single day. 1
Disease Severity Staging
Mild COPD
- Few or no symptoms present 1
- Morning cough, recurrent respiratory infections, or shortness of breath only with vigorous exertion or manual labor 1
- FEV1 60-79% predicted with mildly reduced FEV1/FVC 1
- Often presymptomatic and unknown to healthcare system 1
Moderate COPD
- Breathlessness (±wheeze) on moderate exertion such as physical work or climbing hills 1
- Cough ±sputum production, especially when sputum becomes discolored 1
- Acute worsening associated with infective exacerbations 1
- FEV1 40-59% predicted, often with increased functional residual capacity 1
- Some patients hypoxemic but not hypercapnic 1
Severe COPD
- Breathlessness on any exertion or at rest 1, 3
- Fatigue, weight loss, and anorexia are common systemic features 1, 2
- Wheeze and cough prominent with clinical overinflation usual 1
- Cyanosis, peripheral edema, and polycythemia may be present 1
- FEV1 <40% predicted with marked overinflation 1
- Hypoxemia usual and hypercapnia in some patients 1
Physical Examination Findings
Physical examination is rarely diagnostic in COPD, and physical signs of airflow limitation are usually not identifiable until significantly impaired lung function is present. 1, 2 This is a critical pitfall—the absence of physical signs does not exclude COPD. 2
Useful Physical Signs (When Present)
- Wheezing during tidal breathing indicates airflow limitation 2
- Prolonged forced expiratory time (>5 seconds) suggests airflow limitation 2
- Reduced ribcage expansion and diaphragmatic excursion indicates hyperinflation 2
- Hyperresonance on percussion indicates air trapping 2
- Diminished breath sounds (though a poor guide to degree of obstruction) 2
Signs of Severe Disease
- Use of accessory respiratory muscles (e.g., sternomastoid) implies severe airflow obstruction 2
- Pursed-lip breathing usually indicates severe airflow obstruction 2
- Central cyanosis with significant hypoxemia (though sensitivity is low) 2
- Signs of cor pulmonale: peripheral edema, raised jugular venous pressure, hepatic enlargement, signs of pulmonary hypertension 2
Essential Historical Elements
A detailed history should systematically assess: 1
- Smoking history (most patients are long-term cigarette smokers with >10 pack-years) 1, 2
- Occupational or environmental exposures including biomass fuel for cooking/heating in poorly ventilated dwellings 1
- Age of symptom onset (typically >40 years when presenting with breathlessness) 2, 4
- Pattern of symptom development: more frequent or prolonged "winter colds" and social restriction 1
- History of childhood respiratory infections (associated with reduced lung function in adulthood) 1
- Past medical history: asthma, allergy, sinusitis, nasal polyps, HIV infection, tuberculosis 1
- History of exacerbations or previous hospitalizations for respiratory disorders 1
- Comorbidities: heart disease, osteoporosis, musculoskeletal disorders, malignancies 1
- Impact on quality of life: activity limitation, missed work, economic impact, depression, anxiety 1
Diagnostic Confirmation
Spirometry is required to establish the diagnosis—a post-bronchodilator FEV1/FVC <0.70 confirms persistent airflow limitation. 1 This is non-negotiable; clinical suspicion alone is insufficient. 1
Clinical Predictors with Highest Diagnostic Value
- Smoking history >40 pack-years has the highest likelihood ratio (LR 12) for identifying airflow obstruction 2, 4
- Combination of three findings essentially confirms COPD (LR 156): smoking history >55 pack-years, wheezing on auscultation, and patient self-reported wheezing 2
- Peak flow rate <350 L/min, diminished breath sounds, and smoking history ≥30 pack-years is another strong clinical predictor 4
- Maximal laryngeal height measurement and age >45 years are helpful findings 4
Common Pitfalls to Avoid
- Do not rely on physical examination alone—sensitivity for detecting moderately severe COPD is poor and reproducibility of physical signs is variable 2
- Do not dismiss chronic cough as simply a consequence of smoking without spirometric evaluation 1
- Do not confuse COPD with chronic asthma in older subjects; heavy smoking history, emphysema on imaging, decreased diffusing capacity, and chronic hypoxemia favor COPD 2
- Do not assume all worsening dyspnea is ECOPD—approximately 70% of readmissions after COPD hospitalization result from decompensation of other comorbidities including heart failure, coronary disease, arrhythmias, pneumonia, and pulmonary embolism 5
- Recognize that COPD may be present in completely asymptomatic individuals with mild disease 1
Risk Factors Beyond Smoking
- Asthma may be a risk for developing chronic airflow limitation and COPD 1
- Airway hyperresponsiveness (even without clinical asthma diagnosis) is an independent predictor of COPD and respiratory mortality 1
- HIV infection accelerates onset of smoking-related emphysema and COPD 1
- Tuberculosis has been identified as both a risk factor and potential comorbidity for COPD 1, 6